Linnaeus Therapeutics, Inc. research brief

CIK 1752026 Copy CIK

Generated Nov. 2, 2026, 12:08 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: HADDONFIELD NJ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• April 2, 2026 · D/A · 0001752026-26-000007 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 4992000 USD.

• March 31, 2026 · D/A · 0001752026-26-000006 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 4892000 USD.

• March 13, 2026 · D/A · 0001752026-26-000005 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 4792000 USD.

• Feb. 27, 2026 · D · 0001752026-26-000004 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 4475000 USD.

• Aug. 22, 2025 · D · 0001752026-25-000001 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 1275000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Linnaeus Therapeutics, Inc. research brief,” CIK 1752026, retrieved Nov. 2, 2026, 12:08 p.m.. Cite the specific accessions used. No amounts have been summed.